Truist Financial
EW icon

Truist Financial’s Edwards Lifesciences EW Stock Holding History

Truist Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37M Sell
37,270
-14,235
-28% -$1.19M ﹤0.01% 1114
2026
Q1 		$4.12M Sell
51,505
-3,599
-7% -$297K 0.01% 945
2025
Q4 		$4.7M Buy
55,104
+1,281
+2% +$105K 0.01% 880
2025
Q3 		$4.19M Buy
53,823
+4,817
+10% +$376K 0.01% 971
2025
Q2 		$3.83M Buy
49,006
+2,555
+6% +$191K 0.01% 981
2025
Q1 		$3.37M Buy
46,451
+5,111
+12% +$366K 0.01% 989
2024
Q4 		$3.06M Buy
41,340
+6,676
+19% +$467K ﹤0.01% 1047
2024
Q3 		$2.29M Sell
34,664
-35,731
-51% -$2.6M ﹤0.01% 1178
2024
Q2 		$6.5M Sell
70,395
-6,555
-9% -$580K 0.01% 758
2024
Q1 		$7.35M Sell
76,950
-15,413
-17% -$1.29M 0.01% 739
2023
Q4 		$7.04M Sell
92,363
-49,788
-35% -$3.46M 0.01% 737
2023
Q3 		$9.85M Buy
142,151
+47,975
+51% +$3.86M 0.02% 593
2023
Q2 		$8.88M Buy
94,176
+1,554
+2% +$135K 0.01% 624
2023
Q1 		$7.66M Buy
92,622
+3,355
+4% +$264K 0.01% 673
2022
Q4 		$6.66M Sell
89,267
-10,798
-11% -$832K 0.01% 714
2022
Q3 		$8.27M Sell
100,065
-5,098
-5% -$491K 0.02% 620
2022
Q2 		$10M Sell
105,163
-14,286
-12% -$1.48M 0.02% 572
2022
Q1 		$14.1M Buy
119,449
+8,456
+8% +$949K 0.02% 531
2021
Q4 		$14.4M Sell
110,993
-5,736
-5% -$669K 0.02% 529
2021
Q3 		$13.2M Buy
116,729
+7,600
+7% +$867K 0.02% 541
2021
Q2 		$11.3M Sell
109,129
-2,814
-3% -$265K 0.02% 590
2021
Q1 		$9.36M Buy
111,943
+4,849
+5% +$410K 0.02% 616
2020
Q4 		$9.77M Buy
107,094
+5,140
+5% +$426K 0.02% 606
2020
Q3 		$8.14M Buy
101,954
+15,448
+18% +$1.21M 0.02% 607
2020
Q2 		$5.98M Buy
86,506
+3,007
+4% +$214K 0.01% 675
2020
Q1 		$5.25M Sell
83,499
-15,651
-16% -$1.13M 0.01% 663
2019
Q4 		$7.71M Buy
99,150
+90,411
+1,035% +$7.06M 0.02% 635
2019
Q3 		$640K Sell
8,739
-1,410
-14% -$99K 0.01% 527
2019
Q2 		$625K Buy
10,149
+1,440
+17% +$87.1K 0.01% 540
2019
Q1 		$556K Buy
8,709
+189
+2% +$10.8K 0.01% 556
2018
Q4 		$435K Sell
8,520
-441
-5% -$22.3K 0.01% 569
2018
Q3 		$520K Sell
8,961
-2,901
-24% -$142K 0.01% 578
2018
Q2 		$576K Buy
11,862
+2,235
+23% +$104K 0.01% 557
2018
Q1 		$448K Sell
9,627
-4,047
-30% -$176K 0.01% 593
2017
Q4 		$514K Sell
13,674
-7,830
-36% -$287K 0.01% 582
2017
Q3 		$784K Sell
21,504
-7,560
-26% -$288K 0.02% 508
2017
Q2 		$1.15M Buy
29,064
+8,556
+42% +$312K 0.02% 451
2017
Q1 		$643K Buy
20,508
+1,209
+6% +$37.9K 0.01% 540
2016
Q4 		$602K Sell
19,299
-282
-1% -$9.14K 0.01% 557
2016
Q3 		$787K Buy
19,581
+516
+3% +$19.4K 0.02% 510
2016
Q2 		$633K Buy
19,065
+1,968
+12% +$67.3K 0.01% 557
2016
Q1 		$502K Buy
17,097
+1,746
+11% +$48.2K 0.01% 542
2015
Q4 		$405K Buy
+15,351
New +$399K 0.01% 571
2013
Q3 		– Sell
-24,048
Closed -$269K – 750
2013
Q2 		$269K Buy
+24,048
New +$285K 0.01% 621

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Truist Financial's EW Position: Q2 2026 in Review

Truist Financial reduced its Edwards Lifesciences (EW) stake by 28% in Q2 2026, selling an estimated $1.19M and leaving 37,270 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Truist Financial first reported a position in EW in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.4M in Q4 2021. 597 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Truist Financial held 37,270 shares of Edwards Lifesciences worth $3.37M as of Q2 2026.
  • Truist Financial sold 14,235 Edwards Lifesciences shares in Q2 2026, an estimated $1.19M.
  • Edwards Lifesciences made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1114 holding.
  • Truist Financial first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 44 quarters since.
  • Truist Financial's Edwards Lifesciences position peaked at $14.4M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.